• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血液系统肿瘤疾病及植入Broviac-Hickman导管的儿童发热]

[Fever in children with hematologic neoplastic diseases and implanted Broviac-Hickman catheters].

作者信息

Pilecki O, Wysocki M, Swiatkiewicz V, Kołtan A, Kołtan S, Kurylak A, Kurylak D

机构信息

Katedra i Klinika Chorób Dzieci Akademii Medycznej w Bydgoszczy.

出版信息

Pediatr Pol. 1995 Mar;70(3):213-8.

PMID:8657488
Abstract

A safe and effective method of venous access is important in the care and treatment of patients with malignancies. Thirty-seven Broviac-Hickman catheters were inserted in 32 children with haematological neoplastic disease. The mean indwelling time of the catheters was 7014 days. The catheters were used to administer chemotherapy and other drugs, blood products, and as well as to draw blood. Fever occurred 96 times. Forty-three percent of fever episodes were related to clinically documented infections and in 15% of cases, to catheter-related bacteremia caused by Gram-positive and Gram-negative strains in equivalent proportions. Fever was observed with a two fold greater incidence in patients with severe granulocytopenia (< 0.5 G/l).

摘要

一种安全有效的静脉通路建立方法对于恶性肿瘤患者的护理和治疗至关重要。32例血液系统肿瘤患儿共插入了37根Broviac-Hickman导管。导管的平均留置时间为7014天。这些导管用于输注化疗药物和其他药物、血液制品以及抽血。共发生发热96次。43%的发热事件与临床记录的感染有关,15%的病例与导管相关菌血症有关,革兰氏阳性菌和革兰氏阴性菌引起的菌血症比例相当。严重粒细胞减少(<0.5 G/l)的患者发热发生率高出两倍。

相似文献

1
[Fever in children with hematologic neoplastic diseases and implanted Broviac-Hickman catheters].[血液系统肿瘤疾病及植入Broviac-Hickman导管的儿童发热]
Pediatr Pol. 1995 Mar;70(3):213-8.
2
[Infectious and non-infectious complications of tunneled central catheters in hematologic patients].[血液学患者隧道式中心静脉导管的感染性和非感染性并发症]
Sangre (Barc). 1999 Jun;44(3):176-81.
3
Skin and soft tissue complications in pediatric leukemia patients with and without central venous catheters.有和没有中心静脉导管的小儿白血病患者的皮肤和软组织并发症
J Pediatr Hematol Oncol. 2008 Jan;30(1):32-5. doi: 10.1097/MPH.0b013e31815cc429.
4
[Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter].[患有恶性肿瘤并配备布罗维阿克型静脉导管的儿童的脓毒症]
Pediatr Med Chir. 1995 Mar-Apr;17(2):147-50.
5
Complications of Hickman-Broviac catheters in children with malignancies.希克曼-布罗维阿克导管在恶性肿瘤患儿中的并发症。
Pediatr Hematol Oncol. 2008 Jun;25(5):375-84. doi: 10.1080/08880010802106622.
6
[Central venous catheters with subcutaneous ports for long-term chemotherapy in pediatric oncology].[用于儿科肿瘤长期化疗的带皮下端口的中心静脉导管]
Acta Haematol Pol. 1992;23(3):171-8.
7
Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.对患有留置中心静脉导管的发热性非中性粒细胞减少儿科癌症患者,采用每日一次头孢尼西和庆大霉素进行经验性治疗。
J Pediatr Hematol Oncol. 2008 Jul;30(7):527-32. doi: 10.1097/MPH.0b013e3181754184.
8
[Central venous access: our experience with Hickman and Broviac catheter in children].
Srp Arh Celok Lek. 1994 May-Jun;122(5-6):189-91.
9
Prolonged venous access in cancer patients.癌症患者的长期静脉通路
Eur J Surg Oncol. 1989 Dec;15(6):553-5.
10
Complications of implanted central venous catheters in neutropenic children.中性粒细胞减少儿童植入中心静脉导管的并发症
Am Surg. 2007 Oct;73(10):1079-82.